Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 7, 2015; 21(45): 12954-12962
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12954
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12954
Figure 4 Forest plot of hybrid therapy vs concomitant therapy according to intention-to-treat analysis.
There is no significant difference in eradication rate between 14-d hybrid therapy and 5 to 14-d concomitant therapy with the pooled relative risk is 0.98 (95%CI: 0.93-1.02).
-
Citation: Hsu PI, Lin PC, Graham DY. Hybrid therapy for
Helicobacter pylori infection: A systemic review and meta-analysis. World J Gastroenterol 2015; 21(45): 12954-12962 - URL: https://www.wjgnet.com/1007-9327/full/v21/i45/12954.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i45.12954